Search results
Moderna expects CDC to view its RSV vaccine as equal to rival shots
Reuters· 4 days ago, opens new tab said on Thursday it expects U.S. Center for Disease Control and Prevention (CDC)...
Moderna makes several cost-cutting moves, leans into AI - Boston Business Journal
The Business Journals· 4 days agoAs Moderna Inc. works toward expanding its approved products beyond its Covid-19 vaccine, the...
Moderna beats estimates in Q1 2024, targets RSV vaccine launch in fall By Investing.com
Investing.com· 4 days agoModerna Inc. (NASDAQ:MRNA) reported first-quarter earnings and revenue that came ahead of analyst...
Moderna First Quarter 2024 Earnings: Beats Expectations
Simply Wall St. via Yahoo Finance· 3 days agoModerna (NASDAQ:MRNA) First Quarter 2024 Results Key Financial Results Revenue: US$167.0m (down 91%...
Moderna quarterly sales beat expectations but plummet from previous year
Reuters via Yahoo Finance· 4 days agoModerna on Thursday reported quarterly revenue that beat Wall Street estimates but came in dramatically lower than the previous year when demand for COVID-19 vaccines was ...
Moderna Beats Quarterly Estimates as Cost-Cutting Pares Losses
Bloomberg· 4 days agoModerna Inc. reported a narrower first-quarter loss than Wall Street had expected, as the biotech...
Moderna (MRNA) Set to Announce Earnings on Thursday
ETF DAILY NEWS· 5 days agoModerna (NASDAQ:MRNA – Get Free Report) will be releasing its earnings data before the market opens on Thursday, May 2nd. Analysts expect Moderna to post ...
Moderna reports $1.2bn net loss in Q1 2024
Pharmaceutical Technology via Yahoo Finance· 3 days agoModerna experienced a substantial financial shift in the first quarter (Q1) of 2024, reporting a net loss of $1.2bn - a stark contrast to its net income...
Moderna COVID vaccine sales plummet 91 percent - The Boston Globe
The Boston Globe· 4 days agoSales of Moderna’s COVID-19 vaccine plunged 91 percent from the previous year for the first quarter...
Moderna plants new solid tumor trials for cancer vaccine, weeds PD-1 work after review
FierceBiotech· 4 days agoMuch of Moderna’s focus is on nabbing FDA approval for a respiratory syncytial virus vaccine, a...